DRAP’s survey on drug price hikes irks pharmaceutical manufacturers

Third-party survey initiated in response to public outcry over rising medicine prices after deregulation of non-essential drugs; PPMA voices concerns over lack of industry stakeholder involvement

Citi Pharma’s veterinary subsidiary begins operations, launching 32 products initially

Citi Veterinary Limited projects a turnover of Rs 1.5 billion for FY 2025-26, with plans to establish Pakistan's first dedicated veterinary Active Pharmaceutical Ingredient (API) plant

Searle secures DRAP’s approval for Denosumab biosimilar injections

Company prepares commercial rollout of 60mg and 120mg doses for osteoporosis and oncology care

Pakistan’s pharma sector eyes US market expansion with new tariff advantage

New tariff policy provides Pakistan a competitive edge over India and China; regulatory approvals from US authorities will be crucial for unlocking this potential 

Government approves exemption for import of unregistered lifesaving drugs for hospitals

Exemption covers anti-cancer, cardiac, and essential lifesaving drugs, allowing hospitals to access therapies not yet registered in Pakistan for another five years 

Transparency International says some branded medicines in Pakistan cost up to 4,000% more than generics

Transparency International Pakistan urges government to implement generic medicine policy to address significant price disparities between branded and non-branded drugs

Haleon Pakistan targets expansion to 19 countries, aims for 10% export sales share

Haleon plans to boost exports and local manufacturing, with focus on Vietnam, Philippines and local sourcing to reduce import reliance

Pakistan to import insulin from Russia through pharmaceutical joint ventures

Joint ventures to strengthen insulin supply, with focus on local manufacturing and price regulation

Highnoon Laboratories partners with Bangladesh-based Beximco Pharmaceuticals for strategic collaboration

Both firms sign MoU to distribute and market specialised pharmaceutical products in Pakistan, focusing on key therapeutic areas

Pakistan’s pharmaceutical exports hit 34% growth in FY25, marking a two-decade high

Exports of locally produced medicines reach $457 million, with deregulation policy boosting growth

Pakistan’s retail pharma sector surpasses Rs1.049 trillion in sales 

Data from IQVIA reveals steep price hikes drive growth as medicine consumption shows minimal increase, raising concerns over affordability

PSW, DRAP launch digital certificates to boost pharmaceutical exports 

Alongside Digital Certificate of Pharmaceutical Product, DRAP Clearance Gateway now offers Free Sale Certificate, Good Manufacturing Practice Certificate, and No Objection Certificate for exports; initiative to enhance regulatory efficiency

Citi Pharma submits offers for acquisition of leading pharma company 

Non-binding offer is part of Citi’s strategic expansion plans to become largest pharma firm 

DRAP orders immediate recall of substandard veterinary injection

Zaktyl-20 batch found substandard; authorities warn of therapy failure and drug resistance risks

Searle is lagging the pharmaceutical sector. Its recovery might be just around the corner

The pharmaceutical company has had lackluster numbers in recent times. All that might be about to change